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PREDICTION OF FETAL AGE 
Introduction 
Under certain circumstances it becomes necessary 
for a physician to determine the gestational age of a fetus 
whose maturity is in doubt. These circumstances are many 
and varied. Perhaps the fetus is affected with erythro-
blastosis fetalis as has been previously determined by means 
of maternal antibody titers; should intrauterine transfusion 
be performed or is the fetus mature enough to have a better 
chance of survival in the nursery environment? There occurs 
a time during such a gestation that the morbidity and/or 
mortality associated with intrauterine transfusion equals 
or exceeds that associated with prematurity. If the fetus 
is severely affected, it is at this time that delivery should 
be carried out. Other instances where knowledge of fetal age 
is extremely important include cases of premature labor, 
maternal hypertension, pre-eclampsia, antepartum hemorrhage, 
cesarean section, and hydramnios. In all of these circum-
stances and others not mentioned, there is a question of 
whether to effect immediate delivery by induction of labor 
or by Cesarean section or to postpone delivery for some time 
in order to allow the fetus to mature further. It is in this 
position that the physician places a premium upon the ability 
to determine the gestational age of the fetus. 
But what if the fetus is delivered before term? 
What age the risks of prematurity and are they great enough 
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to warrant any hesitation when the question is whether or 
not to deliver immediately? Without listing all the causes 
for neonatal morbidity and/or mortality, several facts are 
clear. For the infant of less than 1500 grams birth weight, 
the overall mortality rate in the neonatal period exceeds 
60%.47 For the 1500-2000 gram group the mortality rate is 
21% and for the 2000-2500 gram group it drops to 5%. If the 
birth weight exceeds 2500 grams, the mortality rate drops 
to 0.8%. There is also a greatly increased incidence of 
neonatal complications, associated with prematurity. The 
most common of these is respiratory distress syndrome which 
affects 13% of all prematures (By definition, prematurity 
means a birth weight of less than 2500 grams.), over 25% 
of those of less than 2000 grams birth weight, over 50% of 
those of less than 1500 grams at birth. 14 Overall mortality 
for infants so affected averages 50%. Also, to be considered 
is the fact that premature infants who survive to be dis-
charged from the hospital have a mortality rate of approxi-
mately three times that of full-term infants during the first 
two years of life. 29 In addition, there has been noted an 
increased incidence of physical and mental handicaps later 
in life. 13 
Thus, it can easily be seen that when there are 
conditions which endanger the baby, the mother or both, 
two factors must be considered. First, the baby must be 
delivered as soon as possible in order to prevent further 
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harm either to the baby or to the mother; and second, the 
delivery must be postponed as long as possible in order to 
give the baby the best possible chance for survival. The 
optimal time for delivery in most of these cases would be 
a gestational age of 36 weeks which is equal to a birth 
weight of 2500 grams. Generally, the increased survival 
rate beyond this time is overshadowed by the increased 
risk of the disease condition present. 
In order to best reconcile this question of to 
deliver or not to deliver, an accurate knowledge of gesta-
tional age is necessary. It is really not sufficient to 
merely estimate whether or not the fetus is "mature ll (2500 
grams or more) but rather it is imperative to be as accurate 
as possible. A reasonable degree of accuracy might be con-
sidered as plus or minus one week of gestation, a range or 
two weeks. This would allow the physician to realistically 
estimate chances of fetal survival in any case at any time 
during the gestation. Although this idea seems improbable 
at present, this degree of accuracy should be considered the 
future goal in the determination of fetal age. 
What are the present methods of predicting fetal 
age? Are they accurate? The answer to these questions are 
that the present methods have reasonable accuracy when applied 
to large groups of cases but generally fail to be correct 
over two-thirds of the time when applied to an individual 
case. 
5 
Among the commonly used current methods are those 
of patient history (usually correlated with uterine fundal 
height) and X-ray techniques. Some of the newer and conse-
quently less tested methods are those of amniotic fluid cy-
tology, levels of amniotic fluid creatinine and alkaline 
phosphatase and spectrophotometric determination of the 
optical density difference at 450 millimicrons in amniotic 
fluid. 
These methods will be presented listing both their 
advantages and disadvantages as well as the presentation of 
a small series of cases comparing certain of these methods. 
Current Methods of Determining Fetal Age 
Patient's History 
Much may be determined concerning fetal age merely 
by consulting the mother. The application of Naegele's rule 
to the date of the beginning of the last menstrual period 
experienced by the patient is probably the most common means 
of estimating the gestational age of the fetus. Naegele's 
rule states that one may calculate the expected date of 
delivery by subtracting three months from the first day of 
the last menstrual period and adding 7 days. This yields a 
gestation of 280 days from the first day of the last menstrual 
period or 267 days from probable date of ovulation. In large 
series of pregnancies, this calculation is quite accurate. 
In a group of 77,300 live births in which the obstetrical 
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history was relatively certain, there was a mean duration 
of gestation of 280.8 days from first day of last menstrual 
period to delivery with a standard deviation of 12.88 days.16 
However, certain problems do arise with this method, 
not the least of which concerns the patient's reliability. 
Even after overlooking this factor there are several other 
factors which may cast uncertainty upon the tlfirst date of 
the last menstrual period." Bleeding during the time between 
conception and the time of positive or probable diagnosis of 
pregnancy may occur. According to Speert and auttmacher,46 
over 20% of gravidas who eventually deliver viable infants 
may be expected to demonstrate macroscopic vaginal bleeding 
at some time during the first or second trimester. This 
bleeding was found to be three times more common in multi-
gravidas than primigravidas. Also, to be contended with are 
the estimated date of ovulation (and consequently, conception) 
and anovulatory cycles. Collet, et al,ll concluded that the 
incidence of anovulatory cycles was approximately 14% for 
all age groups, the 17-18 year old group showing a 30.8% 
incidence. Chances for an anovulatory cycle to precede a 
given instance of ovulation are about one in seven. This 
alone could cause an error in gestational age of about four 
weeks. Time of ovulation during the cycle is also important. 
Naegele's rule assumes ovulation to have taken place on 
approximately the thirteenth day of the menstrual cycle. 
However, in any given case, ovulation may occur at any time 
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between the fourth and thirty-ninth days of the cycle, 
25% of women in all age groups falling outside of the 
tenth to eighteenth day range. This range may cause the 
expected date of delivery as calculated by Naegele's rule 
to be in error by as much as ten days on the early side to 
three weeks on the late side. 
The time of quickening as reported by the patient 
has also been used to assist in determining fetal age. In 
a reliable patient, the first faint fetal movements are 
usually felt between the eighteenth and twentieth weeks of 
gestation. 17 However, they are frequently spurious and are 
definitely unreliable in the great majority of patient unless 
also detected by the physician and interpreted in the light 
of other findings. 
The use of fundal height to predict fetal age is 
also mentioned here only to point out that its accuracy is 
not good and subject to many variables. It too should be 
interpreted in the light of all other findings. 
X-ray Findings 
Probably the most commonly used method of deter-
mining fetal age at the present time is that of X-ray. X-rays 
are taken of the maternal lower abdomen to include the uterus 
and fetus. They are then examined to determine the presence 
or absence of certain features which develop at reasonably 
predictable times during gestation. Currently the most popular 
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of these features is that of the distal femoral epiphysis with 
the proximal tibial epiphysis supplying "corroborating" 
evidence. 
The distal femoral epiphysis develops at approxi-
mately the 34th week of gestation, the normal range being 
the 32nd to 36th weeks inclusively, the proximal tibial 
epiphysis appearing approximately 2 weeks later. 37 In 
infants born at various gestations it is present (in X-rays 
taken after delivery) in 5% of infants born during the eighth 
fetal month, 33% of those born during the ninth month, 86% 
during the tenth month, and 95% of those born at full term. l 
In these same infants, the proximal tibial epiphysis was 
found in 6% in the ninth month, 40% in the tenth month, and 
85% of the full-term infants. Thus, the presence of the 
distal femoral epiphysis indicates a gestational age of 
approximately 35 to 36 weeks. The presence of both the 
distal femoral and proximal tibial epiphyses indicates a 
gestational age of over 36 weeks. Also to be noted is the 
fact that females develop these growth centers slightly 
earlier than males l and Negroes develop them earlier than 
Caucasian infants. 
However, the distal femoral ossification center 
may also develop in fetuses at earlier ages than 35 weeks. 
In a group of 42 infants weighing less than 2000 grams at 
birth, the distal femoral epiphysis was found in one of 11 
White males, three of six White females, two of 11 Negro 
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males and seven of 14 Negro females. 9 Considering that the 
fetus weighs 2000 grams at approximately 33 1/2 weeks of 
gestation, this means that among these obviously premature 
infants, 14% of the males, 50% of the females, 36% of the 
Negroes and 23% of the White infants would have been in-
correctly diagnosed as mature by X-ray technique. Another 
study of 100 cases lO presents its results as follows: In 
26 cases judged premature both by X-ray and history, 62% 
were premature by birth weight; in 12 cases judged prema-
ture by X-ray but mature by history, 67% were premature; 
in 15 cases judged premature by X-ray but mature by history, 
40% were premature and in 47 cases judged mature by both 
methods, 6% were premature. In other words, when X-ray 
techniques judged prematurity, they were incorrect 37% of 
the time and when judged mature, they were incorrect 15% 
of the time. It must be pointed out that in this last 
group there was a preponderance of cases in which history 
overwhelmingly pointed toward maturity which might tend 
to bias the results in favor of the X-ray diagnosis of 
maturity. 
In the above-mentioned studies the X-rays have 
been taken after delivery. Under normal circumstances it 
is not possible to do this because we are interested in 
the fetal age so that we can decide whether or not to 
deliver the infant. Thus, the maternal soft tissues and 
skeleton must be added to the X-rays thereby complicating 
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the reading of the films. One study35 showed that if the 
distal femoral epiphysis was considered present only if 
it exceeded 4 x 3 mm. in size. In this study, only 78% 
of all full-term infants demonstrated this size growth 
center. One could expect to consistently identify any 
epiphysis present if it were this size; but if smaller, 
the diagnosis could only be considered speculative. 
Further doubt as to the reliability of epiphyseal 
development as a means of predicting fetal age was cast 
44 by Scott and Usher who reported that epiphyseal devel-
opment is late if the fetus is moderately underweight or 
otherwise underdeveloped for a known gestational age. In 
their series, 37% of "malnourished" infants (25% or more 
underweight for known term gestation) failed to radiolog-
ically demonstrate a distal femoral epiphysis. Even when 
present, the growth center averaged 35% less in diameter 
than that found in infants of normal birth weights. The 
proximal tibial epiphysis was absent in 84% of these infants. 
Thus, it may be seen that the X-ray diagnosis of 
fetal age is accurate in about two-thirds of the cases. It 
may be in error in either direction by equal amounts, that 
is, it may predict maturity when the fetus is immature or 
it may predict immaturity when the fetus is mature. If 
both the distal femoral and the proximal tibial epiphyses 
are present, one can fairly safely say that the fetus has 
attained the gestational age of 36 weeks. 
Newer Methods of Determining Fetal Age 
Amniotic Fluid Cytology 
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It was first noted by Kittrich24 that certain 
cells present in amniotic fluid exhibit differential 
staining characteristics that are of assistance in estim-
ating fetal age. He obtained vaginal vault aspirates from 
women who were near term and who had a question of whether 
or not the membranes had ruptured. The aspirates were 
stained with Nile Blue sulfate and examined for the presence 
or absence of cells staining orange or red. If the mem-
branes had previously ruptured, the cells were usually seen 
but were always absent if the membranes were intact. At 
this time Kittrich noted that tlreliability of the method 
seems to vary with the quantity of fat-containing epithe-
lium shed from the skin of the fetus with the liquor--it 
increases with term. n 
Further investigation of this method was per-
formed by Brosens and Gordon in a series of articles. 6 ,7,19 
In these series specimens were obtained by amniocentesis 
or by aspiration of the bag of forewaters at time of de-
livery. Slides were made from the uncentrifuged amniotic 
fluid and stained with 0.1% Nile Blue sulfate. Four types 
of cells are found on slides made in this manner: 48 ,22 
(1) blue-staining anucleate cells probably from the fetal 
epithelium, (2) blue-staining nucleate cells from the amnion, 
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(3) unstained anuc1eate cells which are identical to those 
found in slides prepared from vulvar scrapings, and (4) 
orange-staining anuc1eate cells. These orange-staining 
cells may stain diffusely orange or contain vacuoles which 
appear orange against a rather poorly colored cytoplasm. 
These cells are found in the amniotic fluid generally 
around the thirty-fifth week of gestation and tend to in-
crease in number as term nears. Their origin has been 
traced to the fetal sebaceous glands. In frozen-section 
specimens of stillborns, cells staining orange with Nile 
Blue sulfate were found only in the active sebaceous glands. 
No cells were present if the section contained no sebaceous 
glands. 
For a moment let us examine the differential stain 
used in these studies. Nile Blue sulfate is a commerica1 
name for a differential fat stain which is a mixture of an 
oxazine sulfate (true Nile Blue) and the oxazone (Nile Red). 
Neutral lipids tend to be stained varying shades of red to 
orange while other substances are stained various shades of 
blue. The most commonly used concentration is a 0.1% aqueous 
solution. Other differential fat stains have not as yet been 
reported as being helpful in the diagnosis of fetal age by 
amniotic fluid cytology. Pinacyano1e chloride (Vernitest) 
as described by Averette 3 has been used for this purpose 
but this is not truly a differential fat stain. With this 
test it is difficult to consistently determine the difference 
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between the fetal and maternal cells and contamination 
is a frequent problem. Van Leeuwen, et al,48 have de-
scribed amniotic fluid cytology using the staining method 
of Papanicolaou but this method fails to produce a good 
differentiation between the lipid-containing and non-
lipid-containing cells. However, their description of 
"acidophilic-staining nuclear ghosts" are probably the 
same cells as those described as "orange-staining" by 
Brosens and Gordon. 
In 1966 amniotic fluid cytology was presented 
as a method expressly for the determination of fetal 
maturity. Brosens and Gordon19 correlated weeks of 
gestation with percentage of "orange-staining cells" as 
follows: Less than l%--less than 34 weeks' gestation; 
1 to 10%--34 to 38 weeks'; 10 to 50%--38 to 40 weeks'; 
over 50%--over 40 weeks' gestation. 
Several recent articles have been published 
further evaluating the method. Anderson and Griffiths 2 
found no cells of the sebaceous type prior to 36 weeks' 
gestation in 62 patients. They further stated that "zero 
counts do not necessarily indicate immaturity.1I In their 
method they utilized a Newbauer counting chamber and re-
ported their findings in cells per cubic millimeter. Their 
correlation of counts in excess of 1000 orange-staining 
cells per cubic millimeter with a minimum of 40 weeks of 
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gestation would roughly equal 50% by Brosen's and Gordon's 
method. Counts in the range of 200 to 500 cells per cubic 
millimeter correlate with gestation of 37 to 40 weeks. 
Amniotic Fluid Alkaline Phosphatase 
It was first noted by Beck and Clark4 that the 
maternal levels of plasma alkaline phosphatase were sig-
nificantly elevated over normal nonpregnant levels~ the 
increase being greater during the latter stages of preg-
nancy. The increase was shown to occur in two stages, a 
moderate increase beginning during the mid-portion of the 
second trimester, the increase becoming greater during the 
third trimester. The increase reaches a peak just prior to 
or at the time of delivery. Postpartum there is an abrupt 
decline in the maternal plasma alkaline phosphatase until 
normal nonpregnant levels are reached approximately six 
weeks after delivery. The magnitude of the overall increase 
tends to vary with the individual but ranges are usually 
considered to be 200 to 300% of normal. The increase tends 
to be more or less constant for a given individual in suc-
ceeding pregnancies. 
Although certain of the serum or plasma enzymes 
which increase in the maternal circulation show a corres-
ponding increase in the cord blood (e.g., glutamic oxala-
cetic transaminase and lactic dehydrogenase), alkaline 
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phosphatase is not elevated in the cord blood. Simultan-
eous values in the maternal plasma and the amniotic fluid 
reveal a significant increase in the amniotic fluid levels 
but not to the same extent as the maternal levels. 25 
Maternal values in this study were found to be in the range 
of 5.5 to 19.1 Shinowara-Jones-Reinhart units with an av-
erage of 11.9. Simultaneous amniotic fluid levels (at 
time of delivery) were found to be 2.5 to 12.5 with an 
average of 5.6. 
This degree of elevation of maternal levels 
applies only to single pregnancies, a somewhat larger in-
crease occurs with twin pregnancies. 34 The increase found 
with twin pregnancies averages about 32% higher than single 
pregnancies. Also, to be noted is that the increase is 
greater when the fetus is male than when it is female. 4 
This increase in favor of the males is statistically sig-
nificant during the tenth lunar month and averages 28% 
greater than levels found with female fetuses. 
The source of the elevated maternal alkaline 
phosphatase is not the fetal circulation because, as was 
previously mentioned, fetal (cord blood) levels of alka-
line phosphatase are not elevated at birth. A portion of 
the increase is probably indirectly due to the fetal growth, 
however; that portion being due to an increased mobiliza-
tion of calcium from the maternal skeleton which transfers 
to the fetus. This portion of the alkaline phosphatase 
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increase beings at approximately the fourteenth week of 
gestation, the same time at which the fetal skeleton begins 
to calcify. However, the majority of the alkaline phos-
phatase rise has been traced to one of the isoenzymes of 
alkaline phosphatase which is produced by the placenta. 
This fraction has been characterized electrophoretically43 
but is more easily identified by its unusual ability to 
withstand heat denaturation. 36 "Placental alkaline phos-
phatase" retains virtually 100% of its activity following 
heating to 56 0 C. for 30 minutes. "Regular alkaline phos-
phatase II (originating from bone , liver, etc.) loses over 
90% of its activity under the same conditions. The source 
in the placenta of this isoenzyme has been shown to be the 
syncytial border of the placental villi. 12 In this region 
it remains separated from the fetal circulation by the 
mesenchyme of the villi. The exact method by which it 
appears in the maternal circulation and in the amniotic 
fluid is not certain. 
The continued increase in maternal alkaline phos-
phatase during the latter stages of pregnancy is paralleled 
by the growth of the placenta. As might be expected, in 
cases where the placenta is abnormal in size or function 
(e.g., toxemia) the maternal serum level of heat-stable 
alkaline phosphatase is low. 33 The changes may be even 
more striking in cases of severe fetal distress or fetal 
death. 
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In cases in which the fetus and placenta are con-
sidered to be normal, the alkaline phosphatase levels should 
rise in such a manner as to make possible a correlation 
between alkaline phosphatase level and fetal age. However, 
normal cases show a wide range of values for a relatively 
certain gestational age. Perhaps a portion of the heat-
stable fraction is inactivated by the liver or excreted in 
some manner. If so, possibly amniotic fluid levels of 
alkaline phosphatase or the heat-stable placental iso-
enzyme would give a more accurate picture of the placental 
and fetal growth. 
Amniotic Fluid Creatinine 
It has been noted that certain nitrogenous con-
stituents of the amniotic fluid are found to be elevated 
with respect to the concentrations normally found in the 
31 8 
maternal serum or plasma. ' Among these constituents 
is creatinine, the concentration of which appears to vary 
according to length of gestation. 
The difference in creatinine concentration between 
the maternal serum and the amniotic fluid was first described 
by Makepeace, et aI, in 1931.31 While analyzing amniotic 
fluid specimens for various other substances, four samples 
were checked for creatinine concentration. Three of these 
samples were from term pregnancies, one was obtained by 
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amniocentesis at approximately four months of gestation. 
By the method of Folin and Wu, the following results were 
obtained for the term specimens: 1.67 mg.% (serum) vs. 2.30 
mg.% (amniotic fluid), 1.54 vs. 2.61 and 1.43 vs. 2.00. 
The results from the four month gestations were 1.39 vs. 
1.43. No conclusions pertaining to the cause of this 
elevation were drawn at this time. 
What about the maternal creatinine concentration? 
Does it also rise normally during pregnancy as does the 
amniotic fluid creatinine? Does the amniotic fluid cre-
atinine rise with increasing gestation? And, at what point 
during pregnancy does the rise begin? An extensive study 
of renal function during pregnancy was carried out by Sims 
and Krantz in 1958. 45 They found that the true plasma 
creatinine by the Hare method (to be described later) was 
lower in pregnancy than in a group of nonpregnant controls. 
The values were 0.67, 0.14 mg.% for the nonpregnant con-
trols vs. 0.46, 0.13 mg.% for the pregnant subjects with 
very little overlap between groups. There is no statistic-
ally significant change in plasma creatinine levels during 
pregnancy however there is a prompt return to normal non-
pregnant levels within twelve weeks postpartum. These 
changes are the result of an increased renal function during 
pregnancy, namely, renal plasma flow increases approximately 
25%, glomerular filtration rate increases approximately 50% 
throughout pregnancy and the filtration fraction increases 
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approximately 40% by term and decreases irregularly to 
normal over several months postpartum as opposed to the 
others who promptly return to normal. 
It appears then that maternal creatinine 
is somewhat lower than normal during pregnancy due to 
increased renal clearance function. Why then does the 
amniotic fluid show an increase in creatinine late in 
gestation? According to studies of creatinine transport 
between the fetus and the maternal circulation, creatinine 
appears in the amniotic fluid due to excretion by the 
fetal kidneys.28 These kidneys begin to function at ap-
proximately twelve weeks of gestation but probably do not 
excrete significant amounts of urine until well into the 
third trimester. The creatinine then passes into the ma-
ternal circulation by means of free diffusion through the 
chorioamnion. There is no known transport mechanism for 
this process. 
The attempt to correlate amniotic fluid creatinine 
with fetal age was made by Pitkin and Zwirek in 1967. 38 
Obtaining amniotic fluid by amniocentesis, they analyzed 
it for creatinine concentration only. There was no detect-
able correlation between the creatinine concentration and 
maternal age, parity, or maternal complications of preg-
nancy such as anemia, chronic hypertension, pre-eclampsia, 
diabetes mellitus, urinary tract infection or Rh sensitiza-
tion. It was noted that the creatinine undergoes a gradual 
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increase until approximately the 34th week at which time it 
begins a more abrupt rise. The relationship between a preg-
nancy of 37 or more weeks and amniotic fluid creatinine level 
of 2 mg.% or more was determined to be highly significant 
by statistical analysis (p< 0.05). Also, obtained were 
maternal serum creatinine levels selected at random. No 
variations from the previous observations that maternal 
creatinine levels are slightly lower than nonpregnant levels 
were found. 
Spectrophotometric Analysis of Amniotic Fluid 
The newest of the methods of predicting fetal age 
to be discussed here involves the use of spectrophotometry. 
For several years spectrophotometric analysis of the amniotic 
fluid has been used as the prime means of predicting the 
severity of fetal involvement in erythroblastosis fetalis. 
5,26,30,41,42. 
The use of spectrophotometry for this purpose is 
based on the observations that certain pigments present in 
the amniotic fluid in cases of erythroblastosis fetalis pro-
duce characteristic peaks of absorbance or transmittance when 
they are analyzed on a spectrophotometer. 5 The peak which 
most closely correlates with the degree of affliction present 
is the bilirubin peak which occurs at 450 to 455 millimicrons. 
There are several other peaks present in the range frm 350 
to 700 millimicrons over which the analysis is performed 
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and they must be noted so as to not cause false values to 
be calculated. The most common of these peaks are: meso-
bilirubin--425 millimicrons, unidentified heme pigments--
410 to 415 millimicrons, oxyhemoglobin--415 and 540 and 575 
millimicrons, methemalbumin--630 millimicrons and meconium--
400 to 405 millimicrons. 26 The meconium peak is usually 
present if there is some degree of fetal distress, the 
oxyhemoglobin peaks are present if there is some degree of 
contamination of the specimen with blood during the amnio-
centesis. The spectrophotometer upon which the analysis 
is performed may be of any available type, however, the 
continuous-recording type is used, the wave lengths to be 
recorded should be the following (all in millimicrons): 
350, 365, 380, 400, 410, 415, 420, 430, 440, 450, 460, 
470, 485, 500, 515, 530, 540, 555, 570, 585, 600, 620, 
640, 460, and 700. 26 These pOints will provide a rough 
form upon which the entire curve may be hand drawn. If 
the curve is plotted on semilogarithmic paper on a con-
tinuous recording spectrophotometer at a constant speed, 
a linear plot is obtained. A curve is plotted along the 
so-called base line, that which would be expected if there 
were no bilirubin present in the amniotic fluid. The dis-
tance between this base line and the 450 millimicron peak 
is converted into its corresponding optical density (O.D.) 
difference. This value is then plotted on a chart which 
gives the range of severity of fetal affliction. These 
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ranges correlate well with expected fetal survival rates. 26 ,42 
It has been observed that if serial determina-
tions of this O.D. difference are performed and the plotted 
on a chart with weeks of gestation as the abscissa, definite 
trends can be noted. In general, if the succeeding values 
tend to decrease, the fetus has an excellent chance of 
survival. However, if succeeding values increase, the 
disease is progressing and therapy (intrauterine transfu-
sion or delivery) should be instituted. 
It is this decrease of the optical density peak 
at 450 millimicrons which has been reported as an aid in 
determination of fetal maturity. Mandelbaum, et a1 32 have 
reported that readings of 0.01 or greater (O.D. difference 
at 450 millimicrons) are seen infetuses of 35 weeks' gesta-
tion of less while readings of 0.00 are seen only if the 
fetus is 36 weeks of gestation or more. They noted that 
successive values should be obtained and that the decrease 
to readings of 0.00 may occur very rapidly (less than one 
week). In infants delivered (spontaneously or Cesarean 
section) after the readings were .00, birth weights all 
exceeded 5 pounds, 85% of them exceeded 6 pounds. In the 
group whose readings were greater than .00, all weighed 
less than 5 1/2 pounds except for one infant who died within 
several days of respiratory distress syndrome. 
Speculation on the reason for this decrease in 
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the 450 millimicron optical density peak has failed to yield 
a cause. It is possible that the fetal hepatic function in-
creases at this time so that the bilirubin pigments are 
more efficiently metabolized by the fetus. If this occurred, 
less bilirubin would be available for excretion by the fetus 
and less would appear in the cord blood to be transferred 
across the placental barrier into the maternal circulation 
where it is metabolized by the maternal liver. However, 
at this time, this possibility has not been thoroughly 
investigated. 
Comparison of Newer Methods of Predicting Fetal Age 
Materials 
A total of 16 amniotic fluid specimens were ob-
tained from a total of 13 patients. Each specimen was 
analyzed for creatinine, alkaline phosphatase (10 speci-
mens were also analyzed for heat-stable alkaline phosphatase), 
spectrophotometric analysis to determine the optical density 
difference from normal at 450 millimicrons and cytologic 
examination to determine the percentage of fat-containing 
cells present. 
Ten specimens were obtained by amniocentesis be-
tween the 29th and 38th weeks of gestation. Amniocentesis 
40 was performed using the method of Queenan and Adams with 
minor modifications. All patients were Rh negative and had 
been previously sensitized as was determined by antibody 
titer. 
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Three specimens were obtained at time of Cesarean 
section by aspiration of the amniotic sac just prior to in-
cision of the uterus. An l8-gauge needle and 20 cc. syringe 
was used. In two other cases aspiration failed because of 
an anterior placenta which caused the specimens to be 
grossly contaminated with blood. In another instance no 
fluid was obtained because of oligohydramnios although no 
fetal abnormalities were detected at the time of delivery. 
The remaining three specimens were obtained at 
time of vaginal delivery. A 20-gauge needle and 20 cc. 
syringe was used to aspirate the presenting bag of fore-
waters as soon as the cervix was dilated sufficiently to 
permit the procedure to be performed without danger to the 
fetus. It was noted that this was the least satisfactory 
of the methods of obtaining amniotic fluid. There was an 
excess amount of vernix caseosa in the fluid which was 
rather difficult to remove even by prolonged centrifuga-
tion. Also as will be noted later, labor itself induces 
a mild degree of fetal distress and the amniotic fluid 
may contain meconium at the time of aspiration. This 
adds greatly to the problem of spectrophotometry and negates 
any alkaline phosphatase results. 
Immediately after obtaining the specimens they 
were placed in brown bottles to protect them from the light. 
They were centrifuged within 30 minutes at speeds of 2000 to 
2500 rpm for a minimum of 15 minutes. If the procedures 
were not to be carried out immediately, the specimens were 
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then frozen until the following morning. Prior to analysis 
all specimens were subjected to vacuum filtration through a 
Millipore filter to assure complete removal of all particulate 
matter. 
Methods 
1. Amniotic fluid cytology. 
Prior to centrifugation of the amniotic fluid 
specimens, approximately 0.5 milliliter was removed from 
the specimen and saved for cytologic examination. If the 
examination was not to occur until the following morning, 
the sample was refrigerated overnight. 
Slides for cytologic examination were made as 
follows: Two drops (approximately 0.05 milliliter) of 
uncentrifuged amniotic fluid were placed in the center of 
a clean glass microscope slide. Three drops of 0.1% aqueous 
Nile Blue sulfate stain was then added to the slide. The 
stain and fluid were thoroughly mixed on the slide by means 
of a small glass stirring rod. A coverslip was then placed 
over the mixture. The slide was heated gently for a period 
of two minutes by warming over open gas flame. At no time 
was the temperature sufficient to cause the specimen to boil. 
After cooling, the slide was examined under the low power 
objective on a microscope. Two such slides were examined 
for each amniotic fluid specimen. A count of 200 cells was 
made on each slide and the average of orange-staining cells 
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was determined. For a cell to be counted as "orange-stain-
ing" it was not necessary for the entire cell to stain 
orange, but rather if there were orange or red vacuoles 
present in the cytoplasm the cell was considered positive. 
Red blood cells and white blood cells when present were 
not considered in the total 200 cell count. When clumps 
of cells were present, the number of cells in the clumps 
was estimated as well as possible. In a number of the 
specimens additional slides were prepared but were not 
heated. It was ascertained that if the slides were allowed 
to stand for 1/2 hour, no heating was necessary. Shorter 
periods of time were not tested nor were any slides read 
immediately after preparation and prior to heating. 
2. Creatinine 
Creatinine levels were determined following the 
centrifugation and filtration process. The samples were 
tested by the Jaffe picric acid method21 which has been 
adapted for use with the Technicon Auto-Analyzer. This 
method is based on the development of a yellow to red 
color which is produced by the interreaction of creatinine 
and picric acid in an alkaline solution. This reaction 
also measures certain other lI chromogens" in addition to 
creatinine. 15 Some of these are acetone, pyruvic acid, 
ascorbic acid, proteins, barbiturates, phenolsulfonphthalein, 
and sodium sulfobromophthalein. Their interference with 
the true levels of creatinine is dependent upon the method 
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of deproteinization of the specimen and the time allowed 
for color development. Standardization of the time involved 
such as is controlled on the Auto-Analyzer prevents most of 
the interference caused by these other "chromogens." True 
creatinine levels may only be obtained if the specimen 
is first treated with Lloyd's reagent of fuller's earth. 
The creatinine is adsorbed onto these substances and is 
then removed by elution. The Jaffe reaction is then 
carried out on the Lloyd's reagent or fuller's earth. 
Values obtained by this method are slightly lower than 
those utilizing the Jaffe method. As studied by Hare,45 
true creatinine varies as a percent of the total chromo-
gens but is in the range of 80 to 90% of the values obtained 
by the Jaffe method. 
3. Alkaline phosphatase and heat-stable alka-
line phosphatase. 
Total and heat-stable alkaline phosphatase was 
determined using the Powell and Smith39 modification of 
the Kind and King23 method. In this procedure the substrate 
used is phenyl dis odium phosphate which is hydrolyzed to 
phenol by the action of the alkaline phosphatase. The 
phenol is then reacted with 4-amino-antipyrene and oxidized 
with alkaline potassium ferricyanide which yields a red 
colored product. This is measured colorimetrically and is 
calculated in King-Armstrong units. This entire process is 
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run on a Technicon Auto-Analyzer. For the heat-stable alka-
line phosphatase the amniotic fluid was first heated to 56° C. 
for 30 minutes and then treated the same as the unheated 
specimens which were used for the total alkaline phosphatase 
determinations. 
4. Spectrophotometric analysis. 
Specimens were subjected to spectrophotometric 
analysis over the 350 to 700 millimicron wavelength 
range. The instrument used was a Coleman Hitachi Model 
124 double-beam ultraviolet-visual ratio-recording spec-
trophotometer. A water blank was used to determine 100% 
transmittance. Readings were printed on semilogarithmic 
paper on the continuous recording readout portion of the 
spectrophotometer. The baseline was determined by drawing 
a straight line from the base readings on either side of 
the 450 millimicron peak. The optical density difference 
between this baseline and the peak was then calculated and 
recorded. 
Discussion 
In order to estimate the fetal weight at time of 
examination for specimens not obtained within one day of 
delivery, Lubchanco's growth curve27 was applied to the 
birth weight of the infant and the weight for a given ges-
tation prior to this time was calculated. An example would 
be if an infant were born with a birth weight of 3400 grams. 
This correlates with 40 weeks' gestation on the growth curve. 
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If a specimen of amniotic fluid was obtained 4 weeks prior 
to this time, we note on the curve that the weight at 36 
weeks would be expected to be 2475 grams. This would then 
be assumed to be the fetal weight at the time of examination. 
Although this may cause a minor degree of error in certain 
cases, this approximation is accurate enough for most 
purposes and would be expected to be more accurate than 
the use of Naegele's rule in calculating gestational age. 
Using these weights, graphs correlating weight 
at time of examination with the following parameters were 
prepared: (1) amniotic fluid cytology, (2) creatinine, 
(3) alkaline phosphatase (including heat-stable alkaline 
phosphatase wherever applicable), and (4) optical density 
difference at 450 millimicrons. The graphs are seen on 
the following pages. 
It should be noted that a preponderance of the 
samples (9) were obtained for the purpose of ascertaining 
severity of fetal involvement with erythroblastosis fetalis. 
In each of these cases the maternal Rh antibody titer was 
positive to a titer of 1:8 or greater. The prime purpose 
of attempting to determine fetal age of these amniotic 
fluid samples was to conduct a pilot program to determine 
the feasibility of a larger study to follow. However, we 
can make certain observations from the results obtained. 
The cytologic diagnosis of fetal age as previously 
discussed involves a relatively simple distinction between 
30 
positive cells (those staining orange or red with Nile Blue 
sulfate) and negative cells (those staining various shades of 
blue). This distinction can easily be made under the scan-
ning lens of a microscope after the observer has a certain 
amount of experience with the method. There tends to be an 
extremely rapid rise in percent of positive cells after 
the 36th week of gestation or 2500 grams gestational weight 
as has been previously noted by others. 7,19,2 Prior to 
this time the percentage generally stays below 3%. To 
calculate the cytology by means of a counting chamber and 
reporting the number of positive cells per cubic millimeter 
as has been advocated by Anderson and Griffiths
2 
seems to 
offer no particular advantages over merely performing a 
differential count on a wet mount as was done here. 
As may be noted in Table II, creatinine levels 
in the amniotic fluid form almost a straight-line function 
when plotted against gestational weight. The method used 
to determine these values was the Jaffe method21 which was 
previously discussed in detail. Since the study was started, 
Thiede has advocated the exclusive use of the Hare method 
of determining creatinine in amniotic fluid. How much dif-
ference there actually is between the methods awaits further 
investigation. If fetal kidney function is the prime pro-
ducer of the amniotic fluid creatinine, then the Hare 
method20 would appear to be the best method of determining 
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the level of activity present because the presence of 0.2 
mg.% of "false" creatinine in a given sample could cause an 
error in calculation of 300 grams of fetal weight or approxi-
mately 10 days of gestation according to the results deter-
mined here. Of the methods tested here, creatinine produced 
the most reliable results. It was not affected by the presence 
of bilirubin or meconium in the amniotic fluid nor by the 
maternal factors such as diabetes mellitus. 
Alkaline phosphatase levels in the amniotic 
fluid have not to my knowledge been reported as a test to 
determine fetal age. It was found that values tend to in-
crease with gestational age and weight but that the "scatter" 
of values for a given weight is large. The correlation of 
heat-stable alkaline phosphatase as a percentage of total 
alkaline phosphatase activity for a given gestation produced 
no meaningful results. A completely random character dom-
inated these statistics. Several of the alkaline phospha-
tase readings were inordinately high for the fetal weight 
and it was noted that in each of these three specimens there 
was a definite spectrophotometric peak at 400 to 405 milli-
microns indicating the presence of meconium in the amniotic 
fluid. One of the specimens was grossly stained with meconium. 
The alkaline phosphatase level in this specimen was Ilover 
38 King-Armstrong units," no dilution was performed to further 
determine the exact level. In another specimen whose optical 
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density curve indicated the presence of moderate amounts of 
meconium but was mildly meconium stained produced a level 
of 220 King-Armstrong units which was determined by diluting 
the fluid. 
Spectrophotometric analysis of the amniotic fluid 
specimens for fetal age was hampered to some extent by the 
prime reason for obtaining the majority of the specimens, 
that of determining severity of fetal involvement with 
erythroblastosis fetalis. As has been previously discussed, 
this produces a peak at 450 millimicrons in proportion to 
the degree of fetal involvement. The prediction of fetal 
age by optical density difference at this same wavelength 
is based upon the decrease in this peak to almost zero 
during the latter portions of gestation. For this reason 
only four of the samples demonstrated this strikingly low 
level, all of these having a gestational weight of at least 
2800 grams. Two of the specimens were found to have meconium 
present to such a degree that they completely overshadowed 
the 450 millimicron peak and therefore made the optical 
density difference at this reading usefulness. 
Conclusions 
Realizing the shortcomings of a small series of 
cases, several conclusions may be drawn from the results 
presented here. 
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Of the methods presented, only amniotic fluid 
creatinine fails to be affected by maternal diabetes mel-
litus, hydramnios, erythroblastosis fetalis, meconium 
staining of the amniotic fluid or placental insufficiency. 
The standard deviation from the straight-line values in 
Table II was less than 0.2 milligrams percent for all 
values. 
Among the other methods, cytologic examination 
of the amniotic fluid was the most accurate. The increas-
ing values in this method tend to be logarithmic, the 
steepest increase occurring after 36 weeks' gestation or 
2500 grams fetal weight. 
Spectrophotometric analysis is virtually use-
less in predicting fetal age in cases of erythroblastosis 
fetalis, a group of patients comprising a large percentage 
of those in whom fetal age is in question. 
Alkaline phosphatase levels in the amniotic fluid 
were found to rise significantly with gestational weight 
but tend to vary considerably from case to case. Values 
tend to be spuriously high in cases where there is meconium 
staining of the amniotic fluid and abnormally low when there 
is placental malfunction. 30 Calculation of heat-stable 
alkaline phosphatase activity as a percentage of total al-
kaline phosphatase activity produced no meaningful results. 
Summary 
Several methods of determining the fetal age and 
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weight have been presented with the purpose of determining 
the feasibility of a larger study comparing the reliability 
of several methods upon the same specimen. Each of the 
methods presented is relatively simple, quick to perform, 
available in most hospital laboratories, and considerably 
cheaper than presently used X-ray methods. The methods 
presented, with the exception of X-ray and patient history, 
all require the use of amniocentesis to obtain amniotic fluid. 
While amniocentesis is not without risks, it has an extremely 
low incidence of morbidity. Of more importance is the risk 
of danger to the pregnancy if fetal age is not determined 
so that the proper therapy may be instituted. 
Of the methods compared, creatinine levels in 
the amniotic fluid demonstrated the greatest degree of 
accuracy and reliability. The presently used methods of 
X-ray and patient history are accurate in only two-thirds 
of the cases and variation in a given range of fetal age 
is great. 
It is hope that these studies will be enlarged 
upon and the value of using several methods to determine 
fetal age will be borne out. 
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TABULATION OF RESULTS 
Case Gestational Cytology Creatinine A1k. Phose Heat OD 
No. Weight (gm) (%) (mg.%) K-A u. Stable Diff. 
(% of 
total) 
1. 2300 0.2 1.2 1.6 .084 
2. 2500 0.6 1.6 2.8 .049 
3. 1250 0.1 1.1 1.0 .055 
4. 2000 2 1.6 3.0 .066 
5. 1000 0.1 1.0 2.0 .055 
6. 1500 0.5 1.2 2.0 .092 
7. 3825 5 2.2 4.5 50 .009 
8. 2215 0.1 0.9 2.2 73 .219 
9. 3375 10 1.8 4.0 50 .009 
10. 2800 4 21. 212 32 .000 
11. 4800 30 2.9 1.4 79 .019 
12. 2350 1 1.9 over 38 over 90 .369 
13. 2950 6 2.0 220 5 .120 
14. 2900 3.5 1.8 4 75 .056 
15. 3675 28 1.4 62 8 .070 
16. 1150 0.1 0.9 1 100 .060 
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TABLE I 
Gestational Weight (grams) 
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TABLE III 
Gestational Weight (grams) 




" Alkaline a 
1 4 60 Phospha-
i tase as % 
n of total 
e activity 
P 
h 2 30 
0 
s' • 
a • t 
S @ e (!) 
1000 2000 3000 4000 5000 
* Alkaline Phosphatase (King-Armstrong units) 
• = Alkaline Phosphatase 
6 = Heat-stable Alkaline Phosphatase as % of total activity 
39 
TABLE IV 
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